Financhill
Buy
55

EG Quote, Financials, Valuation and Earnings

Last price:
$336.11
Seasonality move :
1.32%
Day range:
$335.23 - $338.89
52-week range:
$302.44 - $373.23
Dividend yield:
2.38%
P/E ratio:
24.95x
P/S ratio:
0.80x
P/B ratio:
0.92x
Volume:
159K
Avg. volume:
411.8K
1-year change:
-7.22%
Market cap:
$14.1B
Revenue:
$17.3B
EPS (TTM):
$13.48

Earnings Data

Next earnings date for EG
Feb 02
2026
Most recent earnings per share
$6.09
Missed by $8.43
(Oct 27/2025)
Consensus Estimate
$14.52
(Oct 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/02/2026 Q4 $4B -- -- $13.09 --
10/27/2025 Q3 $3.8B $4.3B $6.09 $14.52 -$8.43
07/30/2025 Q2 $4.1B $4.5B $16.08 $14.82 $1.25
04/30/2025 Q1 $3.9B $4.3B $4.92 $7.74 -$2.83
02/03/2025 Q4 $4B $4.6B -$13.60 -$17.42 $3.82
10/30/2024 Q3 $4.2B $4.3B $11.81 $11.73 $0.08
07/31/2024 Q2 $4.3B $4.2B $16.71 $16.64 $0.07
04/30/2024 Q1 $4.1B $4.1B $16.90 $16.03 $0.87
02/07/2024 Q4 $3.7B $3.7B $18.53 $14.65 $3.87
10/25/2023 Q3 -- $4B $15.64 -- --
07/26/2023 Q2 -- $3.7B $16.27 -- --
05/01/2023 Q1 -- $3.3B $9.30 -- --
12/31/2022 Q4 -- $3.3B $12.72 -- --
09/30/2022 Q3 -- $3.1B -$8.22 -- --
06/30/2022 Q2 -- $2.8B $3.11 -- --
03/31/2022 Q1 -- $2.9B $7.56 -- --
12/31/2021 Q4 -- $3.1B $10.83 -- --
09/30/2021 Q3 -- $2.9B -$1.88 -- --
06/30/2021 Q2 -- $3.1B $16.95 -- --
03/31/2021 Q1 -- $2.7B $8.52 -- --
12/31/2020 Q4 -- $2.8B $1.57 -- --
09/30/2020 Q3 -- $2.6B $6.07 -- --
06/30/2020 Q2 -- $2.2B $4.77 -- --
03/31/2020 Q1 -- $2B $0.41 -- --
12/31/2019 Q4 -- $2.2B $5.27 -- --
09/30/2019 Q3 -- $2B $2.56 -- --
06/30/2019 Q2 -- $2B $8.15 -- --
03/31/2019 Q1 -- $2B $8.67 -- --
12/31/2018 Q4 -- $1.8B -$9.38 -- --
09/30/2018 Q3 -- $1.9B $4.84 -- --
06/30/2018 Q2 -- $1.9B $1.70 -- --
03/31/2018 Q1 -- $1.7B $5.11 -- --
12/31/2017 Q4 -- $1.9B $13.85 -- --
09/30/2017 Q3 -- $1.7B -$15.73 -- --
06/30/2017 Q2 -- $1.5B $5.95 -- --
03/31/2017 Q1 -- $1.5B $7.07 -- --
12/31/2016 Q4 -- $1.6B $9.04 -- --
09/30/2016 Q3 -- $1.5B $7.06 -- --
06/30/2016 Q2 -- $1.4B $3.67 -- --
03/31/2016 Q1 -- $1.2B $4.00 -- --
12/31/2015 Q4 -- $1.6B $8.26 -- --

Everest Group Ltd. Earnings Questions

  • How Much did Everest Group Ltd. Generate in Revenue Last Quarter?

    Everest Group Ltd. reported $4.3B worth of top line sales in its most recent quarter.

  • Did Everest Group Ltd. Beat Earnings Last Quarter?

    Everest Group Ltd. announced earnings per share of $6.09 which represents a miss of analyst forecast a $14.52 per share.

  • Is Everest Group Ltd. Profitable?

    Everest Group Ltd. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Everest Group Ltd. EPS Next Year?

    Everest Group Ltd.'s earnings are forecast to grow from $31.80 per share to $30.39 per share next year representing an increase of 40.43%.

  • When is Everest Group Ltd.'s Earnings Date?

    Everest Group Ltd.'s next earnings date is February 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock